Haemophilia drug raises CSL outlook for 2022-2023
MELBOURNE: Broker Wilsons values CSL’s drug development pipeline at $62 per share and the Melbourne-based
MELBOURNE: Broker Wilsons values CSL’s drug development pipeline at $62 per share and the Melbourne-based
FEATURED
Best social housing community design for Global Awards shortlisted
Developer rolls out affordable housing for seniors and low-income residents
Loneliness has deeper impact on mental health than financial hardship
Country set to launch first-ever rental social housing campaign
Architecturally designed social homes now released onto market
Best retirement housing design for Global Awards shortlisted
INNOVATION
